3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Breast Neoplasms
4
Glioma
3
Wilms Tumor
2
Prostatic Neoplasms
2
Glioblastoma
2
Carcinoma, Intraductal, Noninfiltrating
2
Brain Neoplasms
2
Adenocarcinoma, Bronchiolo-Alveolar
2
Adenocarcinoma of Lung
2
Solitary Fibrous Tumor, Pleural
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Pancreatic Intraductal Neoplasms
1
Oligodendroglioma
1
Neurotoxicity Syndromes
1
Neuroblastoma
1
Neoplasms
1
Metastatic Malignant Female Reproductive System Neoplasm
1
Mesothelioma, Malignant
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Germinoma
1
Ganglioneuroblastoma
1
Extensive Stage Small Cell Lung Carcinoma
1
Ependymoma
1
Down Syndrome
1
Diabetes Insipidus
1
Central Nervous System Nongerminomatous Germ Cell Tumor
1
Central Nervous System Neoplasms
1
Interventions
pembrolizumab
136
Nivolumab
115
Ipilimumab
68
Cyclophosphamide
33
Specimen Handling
31
Magnetic Resonance Spectroscopy
28
trametinib
23
binimetinib
22
fludarabine
21
Interleukin-2
20
dabrafenib
19
relatlimab
17
encorafenib
17
Biopsy
17
CTLA-4 Antigen
16
cemiplimab
15
atezolizumab
15
aldesleukin
15
Radiosurgery
15
fludarabine phosphate
14
Opdualag
14
Radiotherapy
11
lenvatinib
10
Blood Specimen Collection
10
lifileucel
9
Paclitaxel
8
Cisplatin
8
Bevacizumab
8
spartalizumab
7
cobimetinib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
Radiotherapy, Conformal
×
1 year
×
Clear all
No trials found.